The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Mycobacterium abscessus: a new antibiotic nightmare
Abstract
The intrinsic and acquired resistance of Mycobacterium abscessus to commonly used antibiotics limits the chemotherapeutic options for infections caused by these mycobacteria. Intrinsic resistance is attributed to a combination of the permeability barrier of the complex multilayer cell envelope, drug export systems, antibiotic targets with low affinity and enzymes that neutralize antibiotics in the cytoplasm. To date, acquired resistance has only been observed for aminoglycosides and macrolides, which is conferred by mutations affecting the genes encoding the antibiotic targets (rrs and rrl, respectively). Here we summarize previous and recent findings on the resistance of M. abscessus to antibiotics in light of what has been discovered for other mycobacteria. Since we can now distinguish three groups of strains belonging to M. abscessus (M. abscessus sensu stricto, Mycobacterium massiliense and Mycobacterium bolletii), studies on antibiotic susceptibility and resistance should be considered according to this new classification. This review raises the profile of this important pathogen and highlights the work needed to decipher the molecular events responsible for its extensive chemotherapeutic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Self-citationBrennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,985
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Bacterial mercury resistance from atoms to ecosystems
Barkay, T., Miller, S. M., & Summers, A. O. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00046-9 · Cited by 1,054
Brown-Elliott, B. A., & Wallace, R. J. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.716-746.2002 · Cited by 909
The Envelope Layers of Mycobacteria with Reference to their Pathogenicity
Daffé, M., & Draper, P. (1997) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60016-8 · Cited by 730
Nash, K. A., Brown-Elliott, B. A., & Wallace, R. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-08 · Cited by 638
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Griffith, D. E., Girard, W. M., & Wallace, R. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1271 · Cited by 518
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Koh, W.-J., Jeon, K., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., Shin, S. J., Huitt, G. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0395oc · Cited by 515
NOSOCOMIAL OUTBREAKS/PSEUDO OUTBREAKS CAUSED BY NONTUBERCULOUS MYCOBACTERIA
Wallace, R. J., Brown, B. A., & Griffith, D. E. (1998) · Annual Review of Microbiology · doi:10.1146/annurev.micro.52.1.453 · Cited by 430
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
Esther, C. R., Esserman, D. A., Gilligan, P., Kerr, A., & Noone, P. G. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.12.001 · Cited by 410
Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus
Ripoll, F., Pasek, S., Schenowitz, C., Dossat, C., Barbe, V., Rottman, M., Macheras, E., Heym, B., Herrmann, J.-L., Daffé, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005660 · Cited by 388
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P., Reed, M. B., & Barry, C. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3492-3501.2005 · Cited by 361
Jeon, K., Kwon, O. J., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., & Koh, W.-J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0704oc · Cited by 336
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V., & Cambau, E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00861-10 · Cited by 333
Self-citationAncestral antibiotic resistance in Mycobacterium tuberculosis
Morris, R. P., Nguyen, L., Gatfield, J., Visconti, K., Nguyen, K., Schnappinger, D., Ehrt, S., Liu, Y., Heifets, L., Pieters, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505446102 · Cited by 333
Role of mycobacterial efflux transporters in drug resistance: an unresolved question
Rossi, E. D., Aínsa, J. A., & Riccardi, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00002.x · Cited by 328
Permeability barrier to hydrophilic solutes in Mycobacterium chelonei
Jarlier, V, & Nikaido, H. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.3.1418-1423.1990 · Cited by 315
Brown, B. A., Wallace, R. J., Onyi, G. O., De Rosas, V, & Wallace, R. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.180 · Cited by 301
Adékambi, T., Reynaud-Gaubert, M., Greub, G., Gevaudan, M.-J., La Scola, B., Raoult, D., & Drancourt, M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5493-5501.2004 · Cited by 299
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Maus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3192-3197.2005 · Cited by 273
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., & Victor, T. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01577-08 · Cited by 263
Moore, M., & Frerichs, J. B. (1953) · Journal of Investigative Dermatology · doi:10.1038/jid.1953.18 · Cited by 262
Steyn, A. J. C., Collins, D. M., Hondalus, M. K., Jacobs, W. R., Kawakami, R. P., & Bloom, B. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052705399 · Cited by 241
Prammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
Shakil, S., Khan, R., Zarrilli, R., & Khan, A. U. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-007-9194-y · Cited by 230
Activities of Linezolid against Rapidly Growing Mycobacteria
Wallace, R. J., Brown-Elliott, B. A., Ward, S. C., Crist, C. J., Mann, L. B., & Wilson, R. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.764-767.2001 · Cited by 226
Rickman, L., Scott, C., Hunt, D. M., Hutchinson, T., Menéndez, M. C., Whalan, R., Hinds, J., Colston, M. J., Green, J., & Buxton, R. S. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04609.x · Cited by 225
Porins in the Cell Wall of Mycobacteria
Trias, J., Jarlier, V., & Benz, R. (1992) · Science · doi:10.1126/science.1279810 · Cited by 222
Transposition of an antibiotic resistance element in mycobacteria
Martin, C., Timm, J., Rauzier, J., Gomez-Lus, R., Davies, J., & Gicquel, B. (1990) · Nature · doi:10.1038/345739a0 · Cited by 222
Self-citationMycobacterium abscessus: an emerging rapid‐growing potential pathogen: Review article
PETRINI, B. (2006) · APMIS · doi:10.1111/j.1600-0463.2006.apm_390.x · Cited by 222
Flores, A. R., Parsons, L. M., & Pavelka (2005) · Microbiology · doi:10.1099/mic.0.27629-0 · Cited by 217
Sanguinetti, M., Ardito, F., Fiscarelli, E., La Sorda, M., D'Argenio, P., Ricciotti, G., & Fadda, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.816-819.2001 · Cited by 210
Kim, H.-Y., Kim, B. J., Kook, Y., Yun, Y.-J., Shin, J. H., Kim, B.-J., & Kook, Y.-H. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00221.x · Cited by 209
Geiman, D. E., Raghunand, T. R., Agarwal, N., & Bishai, W. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-06 · Cited by 197
Meier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J., & Böttger, E. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.381 · Cited by 195
Goldberg, M., Pribyl, T., Juhnke, S., & Nies, D. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26065 · Cited by 188
Suzuki, Y., Katsukawa, C., Tamaru, A., Abe, C., Makino, M., Mizuguchi, Y., & Taniguchi, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1220-1225.1998 · Cited by 177
Viana-Niero, C., Lima, K. V. B., Lopes, M. L., da Silva Rabello, M. C., Marsola, L. R., Brilhante, V. C. R., Durham, A. M., & Leão, S. C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02052-07 · Cited by 173
Role of embB in natural and acquired resistance to ethambutol in mycobacteria
Alcaide, F., Pfyffer, G. E., & Telenti, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2270 · Cited by 172
Mycobacterium abscessus and Children with Cystic Fibrosis
Sermet-Gaudelus, I., Le Bourgeois, M., Pierre-Audigier, C., Offredo, C., Guillemot, D., Halley, S., Akoua-Koffi, C., Vincent, V., Sivadon-Tardy, V., Ferroni, A., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0912.020774 · Cited by 169
Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm
Nguyen, L., & Thompson, C. J. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.05.005 · Cited by 167
Mutations in 16S ribosomal RNA disrupt antibiotic-RNA interactions.
De Stasio, E. A., Moazed, D., Noller, H. F., & Dahlberg, A. E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03494.x · Cited by 164
Davis, N. K., & Chater, K. F. (1992) · Molecular and General Genetics MGG · doi:10.1007/bf00266237 · Cited by 152
Structure and association of ATP-binding cassette transporter nucleotide-binding domains
Kerr, I. D. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0304-4157(01)00008-9 · Cited by 145
Pasca, M. R., Guglierame, P., Rossi, E. D., Zara, F., & Riccardi, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4775-4777.2005 · Cited by 144
Ramón‐García, S., Martín, C., Thompson, C. J., & Aínsa, J. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00550-09 · Cited by 135
Quan, S., Venter, H., & Dabbs, E. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2456 · Cited by 135
whmD is an essential mycobacterial gene required for proper septation and cell division
Gomez, J. E., & Bishai, W. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140225297 · Cited by 134
Nash, K. A., & Inderlied, C. B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2625 · Cited by 133
Guillemin, I., Jarlier, V., & Cambau, E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2084 · Cited by 132
Self-citationShen, G., Wu, B.-D., Hu, S.-T., Lin, C.-F., Wu, K.-M., & Chen, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.008 · Cited by 127
Nessar, R., Reyrat, J. M., Murray, A., & Gicquel, B. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr209 · Cited by 123
Self-citationMeier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 117
Lyu, J., Jang, H. J., Song, J. W., Choi, C., Oh, Y., Lee, S., Kim, W. S., Kim, D. S., & Shim, T. S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.12.012 · Cited by 115
Tebas, P., Sultan, F., Wallace, R. J., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.2.443 · Cited by 114
Nurizzo, D., Shewry, S. C., Perlin, M. H., et al. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00121-9 · Cited by 112
Pulmonary nontuberculous mycobacterial infections: Antibiotic treatment and associated costs
Ballarino, G. J., Olivier, K. N., Claypool, R. J., Holland, S. M., & Prevots, D. R. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.04.026 · Cited by 101
Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts
Cook, J. L. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq035 · Cited by 100
Macheras, E., Roux, A., Neulat-Ripoll, F., Sivadon‐Tardy, V., Gutierrez, C., Gaillard, J., & Heym, B. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00037-09 · Cited by 100
Taniguchi, H., Chang, B., Abe, C., Nikaido, Y., Mizuguchi, Y., & Yoshida, S. I. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4795-4801.1997 · Cited by 91
Responses of Mycobacterium tuberculosis to Growth in the Mouse Lung
Dubnau, E., Chan, J., Mohan, V. P., & Smith, I. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3754-3757.2005 · Cited by 83
Plasmid-encoded mercuric reductase in Mycobacterium scrofulaceum
Meissner, P. S., & Falkinham, J. O. (1984) · Journal of Bacteriology · doi:10.1128/jb.157.2.669-672.1984 · Cited by 81
Koh, S.-J., Song, T., Kang, Y. A., Choi, J. W., Chang, K. J., Chu, C. S., Jeong, J. G., Lee, J.-Y., Song, M.-K., Sung, H.-Y., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03026.x · Cited by 79
Chopra, S., Matsuyama, K., Hutson, C., & Madrid, P. B. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr154 · Cited by 79
Macrolide antibiotic interaction and resistance on the bacterial ribosome.
Poehlsgaard, J., & Douthwaite, S. R. (2003) · PubMed · Cited by 74
In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea
Park, S., Kim, S., Park, E., Kim, H., Kwon, O. J., Chang, C. L., Lew, W. J., Park, Y. K., & Koh, W. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.1.49 · Cited by 73
Woods, G. L., Bergmann, J. S., Witebsky, F. G., Fahle, G. A., Wanger, A. R., Boulet, B., Plaunt, M. R., Brown, B. A., & Wallace, R. J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1676-1682.1999 · Cited by 62
Non‐tuberculous mycobacteria in children with cystic fibrosis: Isolation, prevalence, and predictors
Radhakrishnan, D., Yau, Y. C. W., Corey, M. L., Richardson, S. E., Chedore, P., Jamieson, F., & Dell, S. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21106 · Cited by 58
ABC proteins and antibiotic drug resistance: is it all about transport?
Kerr, I. D., Reynolds, E. D., & Cove, J. H. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331000 · Cited by 51
Mycobacterium bolletiiRespiratory Infections
Adékambi, T., & Drancourt, M. (2009) · Emerging infectious diseases · doi:10.3201/eid1502.080837 · Cited by 41
Mycobacteria: Genetics of Resistance and Implications for Treatment
Sander, P., & Böttger, E. C. (1999) · Chemotherapy · doi:10.1159/000007171 · Cited by 31
Mercury resistance as a selective marker for recombinant mycobacteria
Baulard, A. R., Escuyer, V. E., Haddad, N., Kremer, L., Locht, C., & Berche, P. (1995) · Microbiology · doi:10.1099/13500872-141-4-1045 · Cited by 22
Sha, W., Weng, X., Xiao, H., & He, G. (2003) · PubMed · Cited by 5
Cited by
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
Johansen, M. D., Herrmann, J.-L., & Kremer, L. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0331-1 · Cited by 822
Mycobacterium abscessus Complex Infections in Humans
Lee, M.-R., Sheng, W.-H., Hung, C.-C., Yu, C.-J., Lee, L.-N., & Hsueh, P.-R. (2015) · Emerging Infectious Diseases · doi:10.3201/2109.141634 · Cited by 568
Gupta, R. S., Lo, B., & Son, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00067 · Cited by 529
The Rise of Non-Tuberculosis Mycobacterial Lung Disease
Ratnatunga, C. N., Lutzky, V. P., Kupz, A., Doolan, D. L., Reid, D. W., Field, M., Bell, S. C., Thomson, R. M., & Miles, J. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00303 · Cited by 483
Microbiological Features and Clinical Relevance of New Species of the Genus Mycobacterium
Tortoli, E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-14 · Cited by 355
Metadata
- Authors
- Nessar, R., Cambau, E., Reyrat, J. M., Murray, A., & Gicquel, B.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-30
- Volume
- 67
- Issue
- 4
- Pages
- 810-818
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2096830865
- Cited by
- 799
- References
- 82
- FWCI
- 22.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.